|
BASIC RESEARCH |
|
| Year : 2009 | Volume
: 54
| Issue : 3 | Page : 225-228 |
|
| Determination of the relationship between basal cell carcinoma and human papilloma virus, based on immunohistochemistry staining method |
|
|
M Mokhtari1, A Mesbah2, P Rajabi3, M Ali Rajabi3, A Chehrei2, K Mougouei2
1 Department of Pathology and Surgery, Kashani Hospital, Isfahan, Iran
2 Isfahan Medical School, Isfahan, Iran
3 Department of Pathology and Surgery, Alzahra Hospital, Isfahan, Iran
| Date of Web Publication | 10-Sep-2009 |
Correspondence Address:
A Mesbah
Department of Pathology, Alzahra hospital, Isfahan University of Medical Sciences, Isfahan
Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0019-5154.55629
|
|
 Abstract | | |
Background: Basal cell carcinoma (BCC) is the most common skin cancer among Caucasians, and in most cases, occurs in the sun-exposed areas. In recent years, in addition to many other etiologies such as exposure to UV radiation, and occasionally xeroderma pigmentosa, burns, tattoos, and pox scars, human papillomavirus (HPV) is also considered to have an etiologic role. Different studies were conducted with varied results in this regard. Aims: We evaluate this plausible relationship between HPV and BCC by means of immunohistochemistry (IHC) staining method. Methods: This is an analytic cross-sectional study in which 160 samples were selected randomly consisting of 80 BCC lesions and 80 safe margins. Sampling was done among paraffin-embedded blocks in pathology ward of Kashani and Alzahra hospitals, Isfahan-Iran, from 2004-2007. A section of each block was IHC stained for HPV immunoreactivity (DAKO, Denmark). This was followed by microscopic evaluation in terms of being positive or negative. Results: Fifty seven point five percent of the samples belonged to men and the others to women. In 10%, HPV marker was positive, both in lesion and margin. In 83.8% neither the lesions nor the margins were immunoreactive for HPV. Only in 5 cases (6.3%) the lesion was positive and the margin was negative for this marker. There was no case of immunoreactivity for HPV marker in margins, while it was negative in lesions. Our study results followed by McNemar analysis did not show a significant relationship between BCC incidence and HPV existence. This was consistent in both genders ( P > 0.05, power > 90%). Conclusion: In this study we did not find a significant relationship between BCC and HPV, but based on review of articles it appears that large multicentric studies are to be conducted in this regard.
Keywords: Basal cell carcinoma, immunohistochemistry, human papilloma virus
How to cite this article:
Mokhtari M, Mesbah A, Rajabi P, Rajabi M A, Chehrei A, Mougouei K. Determination of the relationship between basal cell carcinoma and human papilloma virus, based on immunohistochemistry staining method. Indian J Dermatol 2009;54:225-8 |
How to cite this URL:
Mokhtari M, Mesbah A, Rajabi P, Rajabi M A, Chehrei A, Mougouei K. Determination of the relationship between basal cell carcinoma and human papilloma virus, based on immunohistochemistry staining method. Indian J Dermatol [serial online] 2009 [cited 2023 Oct 1];54:225-8. Available from: https://www.e-ijd.org/text.asp?2009/54/3/225/55629 |
| Introduction | |  |
Basal cell carcinoma (BCC), also known as rodent or mariner's ulcer, is the most common skin cancer among Caucasians and represents approximately 75% of all skin cancers. [1],[2] Mortality rates are reported low. [3],[4] But occasionally it may grow aggressively which can lead to extensive tissue destruction. [4],[5] Metastasis frequency is very low (<0.1%), [2],[3],[4],[5] but, at times, has been documented in lymph nodes, lung, bone, and liver. [6],[7],[8],[9]
BCCs are commonly subdivided according to their histological appearances. The major histological patterns include: nodular, morpheaform, and superficial types that have different disease outcome. [3]
The risk for BCC development is associated with environmental factors as well as several patient-dependant factors. [1],[2] BCCs generally occur on sun-exposed areas of the body [1],[2],[10],[11] and high-risk patients are often fair-skinned with a history of burning, not tanning, when exposed to sunlight. [10],[11] Male sex, older age, and more numbers of previous second-degree sunburns are also high-risk factors for BCC development. [1],[2],[11] Patients with BCC of the trunk are at increased risk of developing multiple BCCs, and these tumors will develop at a faster rate compared with BCCs located elsewhere on the body. [12],[13]
Recently, it has been proven that there is an association between smoking and BCC in young women. [14]
Although infection with human papilloma viruses (HPVs) is a major risk factor for several epithelial cancers, [15],[16],[17],[18],[19] an etiologic relationship between HPV and keratinocyte cancers, such as squamous cell carcinomas (SCCs) and BCCs, either in immunocompetent [20],[21] or in immunosuppressed [20],[22] patients, remains unclear. [23],[24],[25]
Several authors have suggested an association between infection with the oncogenic types of HPV and development of BCC. [24],[25],[26],[27] The involvement of HPV in human skin cancer was demonstrated first in patients with a rare hereditary disease 'epidermodysplasia verruciformis' (EV), [28],[29],[30] but to date, a causal connection has not been proven between HPV and BCC in the general population. Therefore we decided to evaluate this questionable correlation.
| Materials and Methods | | |
In this analytic cross-sectional study, 160 paraffin-embedded blocks, microscopically diagnosed as BCC by two expert dermatopathologists, and also their safe margins (80 vs. 80 samples, respectively) were analyzed. Safe margin was defined as a part of perilesional skin that had no evidence of involvement by BCC. This group of samples was considered as control group. These samples were selected from patients admitted to pathology wards of Kashani and Alzahra hospitals (Isfahan-Iran), from 2004-2007.
Blocks without sufficient information (age, gender, and lesion location) or without a safe margin following surgery were excluded from our study. Sampling was done randomly in a simple way and then IHC staining was performed briefed as follows.
Four-micron sections were prepared from paraffin blocks and were placed on poly-l-lysin slides. These slides were dried in an oven at 60°C for 60 min followed by deparaffinization and rehydration. At this stage antigen retrieval was performed by heating in Tris/EDTA buffer (pH 8) for 20 min in a microwave oven at 20% of power. Thereafter, the sections were incubated with HPV monoclonal antibody (1:50) for 20 min at room temperature. Neoplastic cells linked to antibody were visualized at the final step using the LSAB method (Link+Strepavidin-HRP from DAKO, Denmark) according to the manufacturers' instructions.
Finally, the stained slides were evaluated microscopically by this study's administrators separately and the results were documented in terms of being immunoreactive (positive) or not for HPV marker. Immunoreactivity is defined as dark-brown staining of neoplastic cell nuclei.We used a paraffin-embedded block of a proven cervical intraepithelial neoplasia (CIN) as a positive control (recommended positive control for HPV marker) and analyzed our results with McNemar chi-square test by the use of SPSS software (version 12).
| Results | | |
Fifty seven point five percent of the studied samples belonged to men and the other 42.5% were of women. The average age was 64.2 (62.15-66.35) years. The most prevalent tumor locations, the mode groups, were face and nose (33.8 and 23.8%, respectively). On the other hand, the least locations were eyelids and auricles (10 and 15% in sequence) [Table 1]. HPV positive cases in nose and face samples were the most prevalent ones (38.5 and 23.1%, respectively), and on the contrary, it was the least in neck samples (7.7%). Eight cases (10%) were immunoreactive, both in the lesion and margins for HPV; but, in 67 cases (83.8%) the results were negative either in the lesions or in the margins. In five cases of the studied samples (6.3%) HPV was positive in the lesions but negative in margins. Forty percent (40%) of those five cases (with immunoreactive lesions but nonimmunoreactive margins for HPV) were nose samples, followed by one case each of face, neck, and eyelid samples. We found no case in which lesion was not immunoreactive for HPV, while the margin immunoreactive [Table 1] and [Table 2]. Results were also analyzed in women and men separately [Table 3]. Our findings based on McNemar analytic test failed to demonstrate a significant relationship between BCC and HPV. This is also true for both genders ( P > 0.05, power > 90%).
| Discussion | | |
The human papilloma viruses (HPV) are small viruses with double-stranded DNA that have a particular tropism for the epithelium inducing its proliferation, [31] and can be divided into two groups, mucosal and cutaneous. [32] Although the molecular mechanisms of carcinogenesis by HPV have not been completely elucidated, [31],[32] it is apparent that HPV infection is the major risk factor in cervical carcinogenesis. [32]
HPV can produce immortality in keratinocytes and most cervical carcinomas express high-risk E6 and E7 HPV proteins that neutralize cellular tumor suppressor function. [33] In the case of high-risk HPV infection and under favorable conditions, the viral genome is integrated into the host genome, a necessary event for the keratinocytes immortality. [31] During this process the circular viral genome breaks at the level of E1 and E2 regions and never at the level of E6 or E7 regions. [31],[32] E6 and E7 function as transforming genes. The E6 protein binds to the tumor suppressor protein p53 and promotes degradation, while E7 protein complexes and inactivates the Rb protein; together, they disrupt cell cycle regulation. E6 and E7 can cooperate with cellular oncoproteins like ras and myc which enable the virus to act at the level of growth factors and cellular and nuclear metabolism producing oncogenic cells. E6 and E7 can induce DNA mutations of the host cell, probably by causing alterations of DNA repair mechanisms. This means that certain types of HPVs are able to cause malignant lesions even without the action of other cofactors. [31]
In general, the relationship between HPV and BCC (compared with those conducted about HPV and SCC) is not well studied. However, the role of HPV infection as a major factor in some epithelial cancers is substantiated, [15],[16],[17],[18],[19] but its etiologic role in nonmelanoma skin cancers such as BCC and SCC is still unclear. [23],[24],[25] Iftner et al. , suggest that high-risk genital HPV types recently identified as significant risk factor for cervical cancer may also represent a risk factor for nonmelanoma skin cancer in a nonimmunosupressed population. [26]
Nortingthon et al. , in their study suggest that HPV may play a role in the development of some chronic giant BCCs. [24] The findings of Karagas et al. , support a role for HPV types from the genus beta in the pathogenesis of SCC, but not BCC. [23]
Following the analysis of this study results, we observed that the difference between the lesion and the surgical margins in terms of being immunoreactive for HPV was not statistically significant. This difference was also analyzed for each gender, and again no significant difference was seen. Therefore, we thought HPV doesn't play a significant role in development of BCC.
| Conclusion | | |
The study results did not find a significant relationship between HPV existence and BCC development. Such a correlation was neither found in women and men after separate assessments in the present study. But, different and occasionally contradictory results in different studies indicate that large multicentric study is needed for a definite conclusion.
| References | | |
| 1. | Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, Kerl H. Epidemiology and etiology of basal cell carcinoma. Br J Dermatol 2007;157:47-51.  |
| 2. | Lear W, Dahlke E, Murray CA. Basal cell carcinoma: Review of epidemiology, pathogenesis, and associated risk factors. J Cutan Med Surg 2007;11:19-30. |
| 3. | Schiessl C, Wolber C, Tauber M, Offner F, Strohal R. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: Histological and clinical changes, outcome, and follow-up. J Drugs Dermatol 2007;6:507-13. |
| 4. | Shrivastava R, Singh KK, Shrivastava M. Soft tissue metastasis in basal cell carcinoma. Indian J Dermatol 2007;52:206-8.  |
| 5. | Leibovitch I, McNab A, Sullivan T, Davis G, Selva D. Orbital invasion by periocular basal cell carcinoma. Ophthalmology 2005;112:717-23. |
| 6. | Rodriguez C, Barriuso V, Chan LS. Extensive basal cell carcinoma with probable bone metastasis. Cutis 2007;80:60-6. |
| 7. | Robinson JK, Dahiya M. Basal cell carcinoma with pulmonary and lymph node metastasis causing death. Arch Dermatol 2003;139:643-8. |
| 8. | Ting PT, Kasper R, Arlette JP. Metastatic basal cell carcinoma: Report of two cases and literature review. J Cutan Med Surg 2005;9:10-5. |
| 9. | Postlethwaite KR, Courtney DJ, Gosney JR. Basal cell carcinoma with hepatic metastases. Br J Oral Maxillofac Surg 1990;28:111-3. |
| 10. | Corona R, Dogliotti E, D'Errico M, Sera F, Iavarone I, Baliva G, et al . Risk factors for basal cell carcinoma in a Mediterranean population: Role of recreational sun exposure early in life. Arch Dermatol 2001;137:1162-8. |
| 11. | Walther U, Kron M, Sander S, Sebastian G, Sander R, Peter RU, et al . Risk and protective factors for sporadic basal cell carcinoma: Results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol 2004;151:170-8. |
| 12. | Lear JT, Smith AG, Bowers B, Heagearty AH, Jones PW, Gilford J, et al . Truncal tumor site is associated with high risk of multiple basal cell carcinoma and is influenced by glutathione S-transferase, GSTT1, and cytochrome P450, CYP1A1 genotypes, and their interaction. J Investig Dermatol 1997;108:519-22. |
| 13. | Dorfner B, Baum C, Voigtländer V. Multiple superficial basal cell carcinomas following chronic ingestion of sodium hydrogen carbonate containing arsenic. Hautarzt 2002;53:542-5. |
| 14. | Boyd AS, Shyr Y, King LE Jr. Basal cell carcinoma in young women: An evaluation of the association of tanning bed use and smoking. J Am Acad Dermatol 2002;46:706-9 |
| 15. | Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, et al . Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003;104:336-44. |
| 16. | Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH, et al . Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 2004;96:449-55. |
| 17. | Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, et al . Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: Implications for screening and prevention. J Natl Cancer Inst 2006;98:303-15. |
| 18. | Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al . Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20. |
| 19. | D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al . Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56. |
| 20. | Harwood CA, Surentheran T, McGregor JM, Spink PJ, Leigh IM, Breuer J, et al . Human papillomavirus infection and non melanoma skin cancer in immunosuppressed and immuno competent individuals. J Med virol 2000;61:289-97. |
| 21. | Biliris KA, Koumantakis E, Dokianakis DN, Sourvinos G, Spandidos DA. Human papillomavirus infection of non-melanoma skin cancers in immunocompetent hosts. Cancer Lett 2000;161:83-8. |
| 22. | Stockfleth E, Nindl I, Sterry W, Ulrich C, Schmook T, Meyer T. Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg 2004;30:604-9. |
| 23. | Karagas MR, Nelson HH, Sehr P, Waterboer T, Stukel TA, Andrew A, et al . Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006;98:389-95. |
| 24. | Northington M, Tamburin L, Hamza S, Diwan H, Skelton H, Smith K. Giant basal cell carcinoma associated with human papillomaviruses infection. J Cutan Pathol 2004;31:174-8. |
| 25. | Forslund O, Ly H, Reid C, Higgins GA. broad spectrum of human papillomavirus types is present in the skin of Australian patients with non melanoma skin cancer and solar keratosis. Br J Dermatol 2003;149:64-73. |
| 26. | Iftner A, Klug SJ, Garbe C, Blum A, Stancu A, Wilczynski SP, et al . The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res 2003;63:7515-9. |
| 27. | Sass U, Theunis A, Noël JC, André J, Song M. Multiple HPV-positive basal cell carcinomas on the abdomen in a young pregnant woman. Dermatology 2002;204:362-4. |
| 28. | Boxman IL, Russell A, Mulder LH, Bavinck JN, Schegget JT, Green A. Case-control study in a subtropical Australian population to assess the relation between non-melanoma skin cancer and epidermodysplasia verruciformis human papillomavirus DNA in plucked eyebrow hairs. Int J Cancer 2000;86:118-21. |
| 29. | Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM, et al . Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004;150:949-57. |
| 30. | Weber F, Fuchs PG, Pfister HJ, Hintner H, Fritsch P, Hoepfl R. Human papillomavirus infection in Netherton's syndrome. Br J Dermatol 2001;144:1044-9. |
| 31. | González Intxaurraga MA, Stankovic R, Sorli R, Trevisan G. HPV and carcinogenesis. Acta 2002;11:3. |
| 32. | Ishiji T. Molecular mechanism of carcinogenesis by human papillomavirus-16. J Dermatol 2000;27:73-86. |
| 33. | Goodwin EC, DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci USA 2000;97:12513-8. |
[Table 1], [Table 2], [Table 3] |
|
| This article has been cited by | | 1 |
Sun-Exposed versus Sun-Protected Cutaneous Basal Cell Carcinoma: Clinico-Pathological Profile and p16 Immunostaining |
|
| Abdulkarim Hasan, Ahmad M. Kandil, Hasan S. Al-Ghamdi, Mohammad A. Alghamdi, Mohamed Nasr, Suhaib Alsayed Naeem, Wagih M. Abd-Elhay, Osama Khalil E. Mohamed, Hany Sabry A. Ibrahim, Eman Mohamed Ahmed, Ahmed Elsayed M. Abdrabo, Shimaa Abdelraouf Elgohary | | Diagnostics. 2023; 13(7): 1271 | | [Pubmed] | [DOI] | | | 2 |
Nonmelanoma skin cancer in India: Current scenario |
|
| Panda, S. | | Indian Journal of Dermatology. 2010; 55(4): 373-378 | | [Pubmed] | |
|
|
|
|
|
|
|
|
|
